Cresco Labs Inc (CRLBF)

Name: Cresco Labs Inc Financial Statements
Creator: Quarter Results

Healthcare | Drug Manufacturers Specialty Generic

Latest reporting period: 2024-12-31

Latest Quarter

2024-12-31

Revenue

$176M

Net Income

-$4.4M

Operating Margin

11.0%

Free Cash Flow

$38.4M

Debt / Assets

78.9%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Cresco Labs Inc (CRLBF).
Income Statement (Quarterly)	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Revenue	175,909,000	179,783,000	184,356,000	183,472,000
Cost of Revenue	91,883,000	86,345,000	94,747,000	92,083,000
Gross Profit	82,537,000	88,442,000	91,598,000	89,622,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	42,050,000	64,775,000	62,398,000	63,049,000
Operating Expenses	63,131,000	67,095,000	59,218,000	60,459,000
Operating Income	19,406,000	26,343,000	32,380,000	29,033,000
Interest Expense	13,736,000	15,787,000	14,559,000	14,819,000
Income Before Tax	3,055,000	11,322,000	-40,941,000	15,877,000
Income Tax Expense	2,616,000	19,016,000	10,238,000	17,923,000
Net Income	-4,372,000	-10,541,000	-54,332,000	-5,193,000
Per Share
EPS	-0.01	-0.03	-0.16	-0.02
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Cresco Labs Inc (CRLBF).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	667,327,951	724,343,000	770,885,000	842,681,000	821,682,000
Cost of Revenue	357,609,442	359,889,000	408,519,000	435,668,000	415,335,000
Gross Profit	309,718,509	364,454,000	329,886,000	407,013,000	406,347,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	231,254,587	232,272,000	274,634,000	350,653,000	317,804,000
Operating Expenses	231,254,587	257,162,000	435,360,000	350,081,000	318,557,000
Operating Income	78,463,921	107,292,000	-87,823,000	65,747,000	87,790,000
Interest Expense	57,265,211	58,901,000	63,243,000	58,516,000	52,149,000
Income Before Tax	-97,092,413	-10,616,000	-146,902,000	-126,905,000	-256,727,000
Income Tax Expense	45,403,131	49,873,000	32,950,000	88,938,000	40,107,000
Net Income	-142,495,544	-74,438,000	-175,522,000	-215,843,000	-319,597,000
Per Share
EPS	-0.42	-0.22	-0.54	-0.72	-1.52
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Cresco Labs Inc (CRLBF).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	90,920,237	137,564,000	107,964,779	119,341,000
Short Term Investments	0	0	0	0
Net Receivables	38,935,014	51,563,000	51,070,000	56,939,000
Inventory	0	83,293,425	107,237,519	134,608,000
Total Current Assets	258,801,162	294,257,000	276,664,223	326,046,000
Property Plant Equipment	326,596,559	455,503,000	483,702,506	507,986,000
Goodwill and Intangibles	482,635,074	577,478,000	575,231,986	738,145,000
Total Assets	1,195,121,093	1,355,355,000	1,351,516,675	1,583,692,000
Liabilities
Account Payables	16,509,899	13,651,000	27,587,000	28,093,000
Short Term Debt	23,057,000	23,557,000	21,233,000	44,936,000
Total Current Liabilities	99,997,687	94,338,000	199,217,501	280,866,000
Long Term Debt	560,085,869	616,084,000	661,524,000	625,235,000
Total Liabilities	943,078,609	967,179,000	925,639,794	996,009,000
Shareholders Equity
Retained Earnings	-1,497,513,780	-1,352,486,000	-1,259,061,138	-1,076,198,000
Total Shareholders Equity	339,829,433	474,854,000	503,104,728	627,039,000

Balance sheet annual history for Cresco Labs Inc (CRLBF).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	90,920,237	137,564,000	107,964,779	119,341,000	223,543,000
Short Term Investments	0	0	0	0	0
Net Receivables	38,935,014	51,563,000	51,070,000	56,939,000	44,691,000
Inventory	0	83,293,425	107,237,519	134,608,000	136,643,000
Total Current Assets	258,801,162	294,257,000	276,664,223	326,046,000	421,755,000
Property Plant Equipment	326,596,559	455,503,000	483,702,506	507,986,000	457,109,000
Goodwill and Intangibles	482,635,074	577,478,000	575,231,986	738,145,000	884,411,000
Total Assets	1,195,121,093	1,355,355,000	1,351,516,675	1,583,692,000	1,780,463,000
Liabilities
Account Payables	16,509,899	13,651,000	27,587,000	28,093,000	32,278,000
Short Term Debt	23,057,000	23,557,000	21,233,000	44,936,000	40,720,000
Total Current Liabilities	99,997,687	94,338,000	199,217,501	280,866,000	288,394,000
Long Term Debt	560,085,869	616,084,000	661,524,000	625,235,000	584,015,000
Total Liabilities	943,078,609	967,179,000	925,639,794	996,009,000	982,727,000
Shareholders Equity
Retained Earnings	-1,497,513,780	-1,352,486,000	-1,259,061,138	-1,076,198,000	-841,907,000
Total Shareholders Equity	339,829,433	474,854,000	503,104,728	627,039,000	755,554,000

Cash flow quarterly history for Cresco Labs Inc (CRLBF).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-137,778,389	-60,489,000	-178,740,865	-215,843,000
Depreciation & Amortization	56,714,740	65,993,000	70,574,953	57,725,000
Stock Based Compensation	0	14,164,000	16,356,000	23,221,000
Change in Working Capital	27,275,253	36,343,000	15,497,080	13,454,000
Operating Cash Flow	74,165,978	132,480,000	59,637,994	18,741,000
Investing Activities
Capital Expenditure	-35,753,108	-23,486,000	-58,944,505	-86,132,000
Investments	-38,849,378	-19,492,000	-58,944,505	-86,132,000
Investing Cash Flow	-41,416,545	-25,229,000	-45,402,636	-36,577,000
Financing Activities
Debt Repayment	-75,657,641	-43,784,000	-17,848,452	-2,426,000
Common Stock Issued/Repurchased	11,192	-200,000	0	3,087,613
Dividends Paid	0	0	0	0
Financing Cash Flow	-83,524,994	-71,478,000	-27,400,442	-86,643,000
Summary
Free Cash Flow	38,412,870	108,994,000	693,489	-67,391,000
Net Change in Cash	-49,998,891	35,734,000	-13,490,130	-104,592,000

Cash flow annual history for Cresco Labs Inc (CRLBF).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-137,778,389	-60,489,000	-178,740,865	-215,843,000	-319,597,000
Depreciation & Amortization	56,714,740	65,993,000	70,574,953	57,725,000	44,949,000
Stock Based Compensation	0	14,164,000	16,356,000	23,221,000	27,536,000
Change in Working Capital	27,275,253	36,343,000	15,497,080	13,454,000	-29,069,000
Operating Cash Flow	74,165,978	132,480,000	59,637,994	18,741,000	14,487,000
Investing Activities
Capital Expenditure	-35,753,108	-23,486,000	-58,944,505	-86,132,000	-97,053,000
Investments	-38,849,378	-19,492,000	-58,944,505	-86,132,000	-93,875,000
Investing Cash Flow	-41,416,545	-25,229,000	-45,402,636	-36,577,000	-163,933,000
Financing Activities
Debt Repayment	-75,657,641	-43,784,000	-17,848,452	-2,426,000	-219,789,000
Common Stock Issued/Repurchased	11,192	-200,000	0	3,087,613	124,105,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	-83,524,994	-71,478,000	-27,400,442	-86,643,000	235,005,000
Summary
Free Cash Flow	38,412,870	108,994,000	693,489	-67,391,000	-82,566,000
Net Change in Cash	-49,998,891	35,734,000	-13,490,130	-104,592,000	85,328,000